Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: Dupilumab Phase 3 BOREAS/NOTUS Study Results

Event Type:
Webinars
Date:
Tuesday, Oct. 1. 2024 | 2–3pm ET

AMCP Ad Block

AMCP Ad Block